Breaking News & Top Stories
Tacit Therapeutics, a newly launched startup, has secured $19 million in funding to advance its innovative approach to treating brain diseases through RNA editing. This significant investment aims to support…
Recent calls for action emphasize the critical need for early detection of Alzheimer’s disease and related dementias, particularly in Virginia, where over 160,000 individuals are living with the condition. Advocacy…
Scientists at the University of Colorado Anschutz have identified a potential new application for an existing drug that may slow neuron damage associated with Alzheimer’s disease (AD). Their research indicates…
Researchers at Florida Atlantic University have developed a novel deep learning model that distinguishes between Alzheimer’s disease (AD) and frontotemporal dementia (FTD) using advanced analysis of electroencephalography (EEG) brainwave data.…
Research has established a connection between early obesity, low levels of choline, and an increased risk of brain inflammation, which may contribute to memory loss. A recent study indicates that…
In a recent online discussion, Dr. Kelynn Lee, CEO of the Dementia Care Hub, provided critical insights into the differences between Alzheimer’s disease and dementia. In a succinct TikTok video…
A recent study suggests that sodium benzoate, a common food preservative found in sodas and various other products, may enhance memory and cognitive functions in individuals diagnosed with early-stage Alzheimer’s…
Illimis Therapeutics has successfully closed a Series B financing round, securing approximately 58 billion KRW ($42 million) to enhance its drug development efforts targeting central nervous system (CNS) and immune…
Parkinson’s disease affects approximately 1.1 million individuals in the United States alone, making it the second most prevalent neurodegenerative disorder after Alzheimer’s disease. This progressive condition arises when neurons in…